Meta-analysis of urinary liver-type fatty acid-binding protein (L-FABP) has shown potential of L-FABP to detect all stages of DN and predict disease severity and progression in patients with either T1D or T2D (Zhang L et al., 2022). Here, FABP1 is linked to type 2 diabetes mellitus.